The events calendar is for in-person industry events. Please do not post online events to the event calendar.
Jump to a month:
- February 2017
- March 2017
- April 2017
- May 2017
- June 2017
- July 2017
- August 2017
- September 2017
- October 2017
- November 2017
Effectively Addressing and Remediating FDA's Form 483 Findings, Warning Letters and Consent Decree Compliance Issues
February 23-24, 2017
venue to be announced shortly, Atlanta, GA, United States
This seminar will guide the attendee in effectively handling, addressing and remediating FDA's and other related compliance issues associated such as FDA's Form 483, Warning Letter and Consent Decree Compliance Findings. An effective handling and resolution of Compliance issues will prevent further disciplinary actions such as an FDA's Warning Letter or a formal Consent Decree which ends with a costly impact, fines and possible injunctions by the FDA.
February 27 - March 2, 2017
Bethesda North Marriott, North Bethesda, MD, United States
Advanced Manufacturing Science… Emerging Technologies to Modernize Pharmaceutical/Biopharmaceutical Development and Manufacturing IFPAC continues to set precedence as a forum for insightful discussions bringing you the latest trends and real-life applications in the field for the pharmaceutical, biotechnology, generic, food, and other related industries.
IFPAC creates a unique platform to network and discuss the latest trends and technologies with industry, academic, and regulatory leaders. Join your colleagues for the latest developments in RTRT, continuous manufacturing, process validation, risk management, lifecycle management, models & model maintenance, ICH Q12/established conditions, bio-manufacturing/bio-processing, international harmonization, emerging & innovative technologies, control strategies, various analytical techniques, and more.
You will not want to miss out on the high quality presentations and opportunities for networking. Exhibition opportunities are also available. Register Today! www.IFPACglobal.org
February 27 - March 3, 2017
Holiday Inn London Kensington Forum, 97 Cromwell Road, SW7 4DN, London, Non-U.S., United Kingdom
This course is designed to provide a firm grounding in key aspects of European Clinical Pre- and Post-Marketing Safety regulatory requirements. This five-day training course also includes highlights and updates on the pharmacovigilance legislation and the latest news on the international harmonisation and standardisation activities in pharmacovigilance. What you will learn - Definitions and Methods in Pharmacovigilance - Regulatory Aspects in Pharmacovigilance and Practial Examples - Diagnosis of Adverse Drug Reactions - Signal Detection and Signal Management - Modern Technologies and Social Media - Risk Management
March 2-3, 2017
The Desmond Hotel & Conference Center, Malvern, PA, United States
This course is for pharma production, QA & compliance personnel responsible for the review & audit of production batch records & deviation investigations.
March 2-3, 2017
Venue to be announced shortly, Boston, MA, United States
In 1997, the FDA proposed a comprehensive regulatory program for Human Cells, Tissues and Cellular- and Tissue-Based Products (HCT/Ps) outlining the registration and listing procedures for HCT/Ps. This program also differentiates between HCT/Ps that will be regulated via the traditional pathway and those that will undergo approval as new drugs, biologics or devices. In this seminar, we'll discuss the historical context for the use of HCT/Ps in medicine as well as how the HCT/P market is evolving. You will be shown examples of the FDA-approved use of HCT/Ps and what is required for successful product development. This course will also provide an overview of the health authority regulating HCT/Ps, discuss the regulations that govern HCT/Ps, discuss potential product development strategies and provide an overview of product development in the United States.
March 5-9, 2017
McCormick Place, Chicago, IL, United States
Pittcon 2017 will be held March 5-9, 2017, in Chicago, Illinois, at McCormick Place West. Pittcon offers a unique, once a year opportunity to get a hands-on look at product innovations from leading companies and to learn the latest techniques from world-renowned members of the scientific community. Find solutions to all your laboratory challenges.
March 6-7, 2017
Leonardo Royal Hotel, Otto-Braun-Strasse 90, D-10249, Berlin, Non-U.S., Germany
Biologics and Biosimilars Congress 2017 will feature new extended panel discussions with senior executives from prominent organisations. Drawing on their experience and insights these leaders will discuss the challenges, opportunities and future direction of a range promising research fields. The panels will cover themes such as 'advancing immunotherapy', 'ADCs: Design and optimisation' and 'Biosimilars: Communication and Awareness'. In addition round table discussions will offer attendees the opportunity to discuss important topics in the field of Biosimilars. Focusing on regulation, public perception and development issues; the conversation will be facilitated by leaders in the respective fields and enable further exploration of themes raised in the conference agenda. As well as providing ample opportunity for you to ask questions of the panellists, there are over 6 hours of networking time allocated throughout the congress, including the drinks reception at the end of day one. This will help you make the most of the opportunity to talk further with the 60 plus speaker faculty as well as the other delegates and meeting's sponsors and exhibitors. Attracting industry, regulatory and academic experts working in all areas of protein and antibody research, the 3rd Biologics and Biosimilars Congress will offer an opportunity for you to take home cutting edge strategies, case study examples, regulatory guidelines to allow you to keep abreast of this dynamic field. This will be achieved through a vibrant exhibition room full of technology providers showcasing their solutions, networking breaks, expert-led case study presentations and incisive panel discussions, divided over four tracks. - Antibody Based Therapeutics - Protein Biotherapeutics - Biosimilars
March 8-9, 2017
Hilton Tower Bridge, 5 more london place, tooley street, SE1 2BY, London, Non-U.S., United Kingdom
The 10th Clinical Innovation and Partnering World conference is your opportunity to engage and sit alongside the pioneers who are disrupting clinical research and getting medicines to patients faster. The event will cover a range of different topics including: . mHealth and the rise of wearables . Patient centric clinical trials . Relationship management . Outsourcing strategy . Opportunities for clinical innovation in the future
March 14-16, 2017
CCIB, Barcelona, Non-U.S., Spain
15th Annual eyeforpharma Barcelona 2016 is Europe’s largest commercial pharma meeting of 1000+ industry leaders focused on commercial innovation, engagement strategy, patient centricity and stakeholder collaboration. 1000+ delegates, 80+ senior level speakers, 3 tracks: http://goo.gl/2929t3 Speakers Include: Gregory Behar, CEO, Nestle Health Science Richard Francis, CEO, Sandoz David Ricks, President Lilly Bio Medicines, Lilly Why Barcelona? Collaborative setting: In 2017, our aim is to ensure your key stakeholders are present to advance partnerships with healthcare, technology, patients and patient associations An inspiring agenda: As you undergo a commercial evolution we will provide 3 targeted tracks, intimate workshops and stakeholder sessions to help direct your journey 1000+ in attendance: If you are looking for one commercial meeting to attend in 2017, Barcelona will be sure to give you the most senior networking opportunity possible For more information visit: http://goo.gl/2929t3
March 14-16, 2017
CCIB, Centre Convencions Internacional Barcelona, Placa de Willy Brandt, 11-14, 08019, Spain, Barcelona, Non-U.S., Spain
The role of medical affairs is changing. What was once considered a support function is now thought of as a strategic partner alongside commercial and RandD. The insights that you generate will help shape decisions across the entire organisation and the responsibility placed on medical affairs department has never been so high! That's why eyeforpharma's inaugural Medical Affairs summit (14-16 March, Barcelona) will focus on the core issues driving this change! From real world evidence and stakeholder engagement to MSL training and medical education; this meeting will see leading experts from across the globe come together to discuss, share ideas and challenge the future of medical affairs. Make sure you don't miss this unique opportunity to join like minded colleagues and senior speaker faculty. For the full business-critical agenda and speaker line-up, download the brochure today
Quality and GMP Compliance for Virtual Companies (Pharmaceutical, Medical Device & Biologics Industries)
March 16-17, 2017
Venue to be announced shortly, San Diego, CA, United States
Today, many companies operate on an outsourcing model. This is very common for companies who are evolving from being mainly development-focused to a point where they are entering latter stages of Phase 2 or Phase 3 clinical trials, and plan to have a product ready for market approval in the coming months. Most such companies are small, and may not have deep expertise in QA and GMP compliance, relying on their partners to cover those areas. Companies who outsource the majority of operations through the use of Contract Manufacturing Organizations (CMOs), Contract Research Organizations (CROs) and Contract Laboratories, however, remain responsible for the quality and compliance status of the products they send to the clinic or to the marketplace. In this two day workshop conference you will learn the requirements and expectations of major health care regulators that are applicable to "virtual" companies. You will learn how to diagnose your company's needs based on which GMP and GCP-governed operations you retain and which you outsource; what the current expectations and best industry practices are for selecting, qualifying and monitoring your contractors to ensure they are meeting your requirements; and how to build a quality system framework that is not excessive for your current needs, but has the structure and integration to "grow with you" as the scope your operations change in the coming months and years. You will also learn best practices for managing a regulatory inspection, with emphasis on FDA, EMA and Health Canada, but applicable to most other major agencies as well. Note: Use coupon code NB5SQH8N and get 10% off on registration.
March 20-21, 2017
Copthorne Tara Hotel, London, Non-U.S., United Kingdom
SMi is proud to present the return of their 11th annual Paediatric Clinical Trials Conference, 20th – 21st March 2016, London. Join us as we discuss current clinical trials, implementation and paediatric drug development in a series of interactive conference sessions, roundtables and workshops led by leading industry experts. Gain information on methods to improve clinical recruitment, appreciate ethical issues and navigate regulations when planning and executing a paediatric clinical trial. We will be exploring the complexities of paediatric drug formulation and helping you determine clinical endpoints.
March 20-21, 2017
Copthorne Tara Hotel, London, Non-U.S., United Kingdom
SMi presents the 2017 19th annual Superbugs & Superdrugs conference, taking place on 20 -21 March in Central London. Expanding horizons on the growing threat of anti-microbial resistance (AMR) for almost two decades, the flagship show in the global Superbugs portfolio of events will once again play host to an international audience of scientific leaders, funding bodies and drug discovery specialists, providing a focal point to push industry collaboration through updates on clinical advancements and investment opportunities. The threat of AMR is regularly making front page news but what is the industry actually doing? Are drug manufacturers any closer to finding a solution and how is the government helping? These will be just some of the questions answered through powerful keynote addresses delivered by an expert panel of speakers A must attend for both new and seasoned stakeholders involved in AMR and infectious disease, the industry’s premier event will provide a perfect platform for its growing "superbugs" community to network, exchange novel solutions and consolidate current strategies. FEATURED SPEAKERS: Sumathi Nambiar, Dir, Division of Anti-Infective Products, FDA Richard Bax, Senior Partner, TranScrip Lloyd Czaplewski, Dir, Chemical Biology Ventures Chris Houchens, Branch Chief, BARDA James Anderson, Head of Corporate Government Affairs, GSK Aileen Rubio, Head of Biology, Spero Therapeutics David Williams, CEO, Discuva Martin Everett, CSO, ANTABIO SAS Jean de Gunzburg, Scientific Director, Da Volterra William J Weiss, Dir, Pre-Clinical Services, UNT System College of Pharmacy AGENDA HIGHLIGHTS: EXCLUSIVE: Regulatory perspective on drug development by the Director of the FDA Antibiotics Division Latest developments in antimicrobial peptides and chemotherapy Comprehensive overview of government funding initiatives Updates on clinical progress Spotlight on animal models in drug discovery
March 20-23, 2017
New York City, NY, United States
DCAT Week is the premier business development event for companies engaged in and supporting pharmaceutical development and manufacturing. Its unique model brings together members for high-level strategic meetings with key decision makers, timely educational programs and important networking opportunities. It is organized by the Drug, Chemical & Associated Technologies Association (DCAT).
March 21-23, 2017
Javits Center, New York, NY, United States
At INTERPHEX, find all of the State-of-the-Art Solutions you need to Cost Effectively Develop and Manufacture Product. INTERPHEX is a premier pharmaceutical, biotechnology, and medical device development and manufacturing event and sponsored by Parenteral Drug Association (PDA). Dedicated to Innovation, Technologies and Knowledge, the show focuses on the entire product development life cycle. Held in New York City, it brings over 10,000 global industry professionals together with 600+ suppliers through a unique combination of our no cost technical conference, exhibits, demonstrations, workshops, partnering opportunities, and networking events. . INTERPHEX offers annual national and international industry events and educational opportunities around the world. Follow INTERPHEX on Facebook, LinkedIn, Instagram, YouTube, and Twitter. IPX Blog continues the learning beyond the show floor. For more information, visit www.INTERPHEX.com.
March 27-28, 2017
Sheraton Philadelphia University City Hotel, Philadelphia, PA, United States
ExL Events' Product Complaints Forum brings together industry experts to discuss best practices for handling all types of product complaints in accordance to FDA requirements. You will hear from representatives of most innovative pharmaceutical and medical device companies currently handling complaints in the United States and around the globe. Our expert speaking faculty will enable you to: 1. Gain a better understanding of the complaints and recalls landscape from conception to conclusion 2. Discuss and differentiate best practices in both medical device and pharmaceutical complaints 3. Prevent product mishandling and ward off inspections 4. Accelerate complaint and recall management to minimize damage 5. Navigate the intricacies of the product complaint and recall regulatory landscape This event is an incredible opportunity to hear a wide spectrum of perspectives from key industry leaders from pharmaceutical, biotechnology and medical device companies, as well as to network with colleagues currently facing similar challenges. The knowledge that you will gain is sure to pay immediate dividends, increasing the quality, efficiency and effectiveness of your current product complaint processes.
March 27-28, 2017
Holiday Inn Kensington Forum, London, Non-U.S., United Kingdom
SMi proudly presents its exclusive conference on Drug Discovery, taking place on 27th and 28th March 2017. In recent years, the Pharma/Biotech industry has undergone radical changes which have increased are understanding of drug discovery and development, however there are still many hurdles that the industry face. The gap between a laboratory discovery and an approved drug on the market is a decade-long process of laboratory testing, evaluation in animal models and human clinical trials that can cost hundreds of millions. The conference aims to bridge the gaps in approval for drug discovery and development by discussing the latest scientific breakthroughs, exploring novel technologies and approaches that can be used to overcome drug development challenges. The conference will bring together industry leaders who will highlight future opportunities for novel therapeutic discovery. Some of our featured speakers include Lorenz Mayr, VP and Global Head, AstraZeneca Guido Hanaeur, Scientific Director Translational Medicine, Takeda Ulrich Schopfer, Executive Director, Head Integrated Lead Discovery, Novartis Yolanda Chong, Principal Scientist, Johnson and Johnson Matthias Frech, Director, Molecular Interactions and Biophysics, Merck Serono Wengard Czechtizky, Head of Chemistry, Sanofi Ulrich Schopfer, Executive Director, head Integrated Lead Discovery, Novartis Stephen Pickett, Senior Scientific Investigator, GSK Plus more from AbbVie, UCB Pharma, Eli Lilly, TissUse, Heptares and more. For more information and to register, kindly visit http://www.drug-discovery.co.uk/evvnt. Early Bird rates: Book by 30 November to save GBP 400 Book by 16 December to save GBP 200 Book by 31 January to save GBP 100
March 29-31, 2017
Scottish Exhibition & Conference Centre - SECC, Glasgow, Non-U.S., United Kingdom
The DIA EuroMeeting allows you to debate the issues across the entire drug development value chain during the conference & find solutions within the exhibition with 2,500+ other cross functional thought leaders. You will hear the latest solutions and challenges in healthcare. You will have plenty of opportunities to network and build relationships with trend setters in e.g. the areas of regulatory science, clinical research and operations, value demonstration leads and patient advocates. The resulting knowledge transfer and lasting partnerships will reduce the burden of regulatory barriers, benefiting your business now and further down the line. Themes such as Innovation, Globalisation and Value & Access will utilise input from top speakers from different faculties to achieve solutions that can be applied in your own real-life settings. Other themes will close with roundtable discussions with the speakers and a summary given by the theme leader. We trust that this additional new format will further strengthen the ability to develop new insights and opinions at our conferences - for your benefit. Theme 1 Globalisation - What are the current successes and challenges? Theme 2 Innovation - What are the key success factors? Theme 3 Current Challenges in Clinical Research Theme 4 eHealth/Big Data/Master- and Reference Data Management Theme 5 Pharmacovigilance Theme 6 Regulatory Science Theme 7 Medical Devices and Combination Products Theme 8 HTA, Value and Access Theme 9 Information on Medicines, Medical Writing and Dossier Generation Theme 10 Special Populations Exhibiting Opportunities at the EuroMeeting. We invite you to take your brand, product or message to the next level by joining an elite group of professionals who have one goal in mind: to help you reach your full potential. 2,500+ individual
April 3-5, 2017
Anaheim Marriott, Anaheim, CA, United States
PDA’s flagship Annual Meeting offers the latest and most comprehensive information on a broad range of topics related to processing, manufacturing and quality control. It provides the ideal forum for sharing best practices and learning how industry is applying novel approaches for development and commercialization of bio/pharmaceutical products.
The 2017 Annual Meeting, the theme of which is Manufacturing Innovation: The Next Wave of Sterile and Biopharmaceutical Science, Technologies & Processing, explores the future of bio/pharmaceutical science and technology. Examine current and future trends in advanced therapeutic strategies, immunotherapy, gene-based personalized medicine and cell-based therapies, next-generation processing and facilities, and big data applications for process design and optimization. Breakfast Sessions and Interest Group meetings provide the opportunity to engage in interactive discussions on a wide range of topics. And don’t miss the Exhibit Hall where you can interact one-on-one with service providers and vendors showcasing their latest offerings and technologies!
Stay on for the 2017 PDA Cell and Gene Therapy Workshop immediately following (Apr. 5-6) and the 2017 PDA Annual Meeting Course Series (Apr. 6-7).
April 3-6, 2017
Crowne Plaza Barcelona - Fira Center, Avenida Rius i Taulet 1-3, 08004, Barcelona, Non-U.S., Spain
This year the ISPE 2017 Europe Annual Conference will focus on 'Pharma Manufacturing 2025' and the way to achieve a modern, agile, and flexible production landscape. Prominent questions will be explored and discussed during the conference. What will the main regulatory trends be by 2025? How will the current technology platforms evolve? What will the required skillsets and capabilities of the future workforce be? What does the facility of the future look like and how will operations be managed? How can we guarantee safe supply: no counterfeits, no drug shortages? We will take a closer look at how the following industry trends will impact the pharmaceutical industry: . Change from small to large molecules – is Bio an over-emphasised trend? . Complete revision of Annex 1 – a global template? . Global harmonisation of regulation – or more barriers? . Industry 4.0 and complete digitalised operations and full automation – is our current product design fit for being manufactured automatically? Conference Highlights 3 April Executive Forum – The management perspective on future challenges in pharmaceutical operations 4–5 April Keynotes on Manufacturing, Aseptics, and Quality Four Tracks: Factories of the Future | Advanced Aseptic Processing | Clinical and ATMP Supply Chain | Data Integrity and GAMP | 6 April Plant Tours in the Barcelona area: Grifols, Almirall, and the Biomedical Research Park For exhibition opportunities don't delay and contact us, space is selling quickly!
April 3-6, 2017
McCormick Place, Chicago, IL, United States
Automate showcases the full spectrum of automation technologies and solutions. From traditional industrial applications to cutting edge new technologies, you'll find ways to automate every process in your company.
April 10-12, 2017
The Grand Hyatt, Washington, DC, United States
With new vaccine formulations and technology platforms, vaccine developers need to have the right processes in place to manufacture them during clinical trials and at commercial scale. Use this opportunity to meet with the manufacture and bioprocessing leads who need services for all of the latest manufacturing challenges, from formulating and manufacturing adjuvants, mRNA platforms, VLPs and viral vectors, to technology transfer and continuous manufacturing. Bioprocessing and Manufacturing Conference 2017 is one of the 7 different conference streams at the 17th annual World Vaccine Congress Washington. By bringing seven events together under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture. Take just three days out of the office to meet over 600+ potential customers who need to find solutions to their challenges. For more information and to register, please visit http://goo.gl/Wsi2bO
April 10-12, 2017
The Grand Hyatt, 1000 H Street NW, 20001, Washington, DC, United States
This event will tackle the latest issues affecting vaccines for respiratory diseases including influenza, TB, RSV and MERS to stimulate the industry to develop more effective vaccines. Ensure you use this event to make people aware of your expertise around key topics such as universal and seasonal flu, maternal immunization and pandemic preparedness. Influenza and Respiratory Vaccine Conference is one of the 7 different conference streams at the 17th annual World Vaccine Congress Washington. By bringing seven events together under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture. Take just three days out of the office to meet over 600+ potential customers who need to find solutions to their challenges. For more information and to register, please visit http://goo.gl/GirnRV
April 19-23, 2017
RAI Amsterdam, Amsterdam, Non-U.S., Netherlands
Anyone interested in hepatology, gastroenterology, internal medicine, cell biology, transplant surgery, infectious diseases, microbiology and virology, pharmacology, pathology and radiology and imaging should attend. Specialists share recent data, present studies, and findings, and discuss the hottest topics on liver disease. The annual Congress attracts in excess of 10,000 delegates and 250 media representatives from all over the world making this a truly international networking opportunity!
April 20-21, 2017
venue to be announced shortly, San Francisco, CA, United States
Good Clinical Practice (GCP) is a term used to describe a collection of various FDA regulations that govern the conduct of clinical trials. It includes regulations which apply to Sponsors and Contract Research Organizations (CROs) who run the trials, the clinical trial sites and Investigators who conduct the research, the Institutional Review Boards ("IRBs" or Ethics Committees) who oversee the conduct of the trials, and includes other aspects such as avoidance of financial conflict of interest on the part of clinical investigators. The FDA conducts inspections at all of these levels to determine if there has been compliance with GCP, and if not, the agency may take any of a variety of enforcement actions
April 20-21, 2017
Sheraton Philadelphia Society Hill Hotel, Philadelphia, PA, United States
It’s eyeforpharma Philadelphia’s 15th year; already the largest, most senior and most influential forum for commercial pharma executives, but now in line for a reboot as we aim to position our industry ahead of the curve. Victory requires far more than just SFE, MCM and KAM – it means becoming the health partner of choice. We, as patients, are becoming consumers. We’re looking for value. We expect quality and real-time delivery. We are more than just empowered – we’re in charge. This is your opportunity to join the discussion with 2 days of expert presentation, interactive panels, keynote presentations and exclusive networking. Join the most forward thinking speaker from across North America including C-level, VPs and industry leaders from Shire, Otsuka, GSK, Novartis, Pfizer, Google, Sanofi, Takeda and many more. This is the ideal place to ensure your commercial strategy is prepared for 2017 and beyond. Full meeting details here https://goo.gl/HAFSus
April 24-25, 2017
Novotel London West, London, Non-U.S., United Kingdom
Oxford Global is proud to present our 10th Annual Proteins and Antibodies Congress. In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 50 speakers will present a full conference programme covering the topics outlined below. These topics have been compiled as a result of a comprehensive research process undertaken with an expert advisory board with members including Executive Directors and Professors from global pharmaceutical organisations and leading research institutions. Delegates will also have the opportunity to attend our co-located inaugural Biotherapeutics Congress. The congress will cover 5 interactive streams: Advances in Protein Engineering, Design & Selection; Updates in antibody structure and dynamics; Cloning, Expression, Purification & Analytics; Antibody Biotherapeutics and Protein Biotherapeutics.
April 24-25, 2017
To be confirmed, London, Non-U.S., United Kingdom
Oxford Global Conferences are proud to announce the 4th Annual Peptides Congress, taking place on 24 – 25 April 2017 in London, UK. This highly anticipated conference provides a unique opportunity for over 400 senior-level delegates to engage in scientific discussions about the current research results and latest advancements that help the industry going forward.Over 25 presentations and case studies focusing on the key advancements in peptides technologies, chemistry, formulation & delivery as well as peptide therapeutics Two-day interactive conference addressing three main themes: - Recent Progress in Peptide Technologies & Manufacturing - Peptide Discovery & Development: Peptide Chemistry, Formulation & Delivery - Advances in Peptide Therapeutics Co-located with the 10th Annual Proteins & Antibodies Congress, the event will have 14 pre-scheduled one to one meetings, exhibition and informal networking opportunities The 2017 Peptides Congress features a revamped conference agenda that will focus on peptide technologies & manufacturing as well as peptide chemistry, formulation & delivery on Day 1. Stream 1 will feature presentations covering recent progress in peptide synthesis, advancements in peptide screening as well as updates in peptide stabilisation and efficient manufacturing of peptides. In Stream 2 our highly acknowledged speakers will focus on such hot topic areas as utilising macrocyclic peptides in drug discovery, novel strategies for peptide formulation and devices for the effective delivery of peptides. The areas of enhancing the immunogenicity of peptides as well as peptide analysis & quantification will also be addressed. Day 2 of the event will focus on peptide therapeutics. Novel case studies from exciting research areas such as diabetes, metabolic diseases and well as abdominal pain disorders will be covered. Renowned experts will also deliver talks on peptide drug conjugates, peptide-based vaccines and immunotherapies.
April 24-26, 2017
Argonaut Hotel, 495 Jefferson Street, 94109, San Francisco, CA, United States
Digital Marketing for Medical Devices West is designed to provide device marketers with the tools they need to improve brand recognition, increase sales and ensure their products are front-of-mind for their customers, whether they are surgeons, patients and/or hospital administrators. As part of the longest-running and best-attended event series specifically for device marketers, the 6th Digital Marketing for Medical Devices West conference is a must-attend event for anyone looking to learn from industry leaders and network with peers.
April 25-26, 2017
To be confirmed, London, Non-U.S., United Kingdom
Oxford Global is proud to present its Inaugural Precision Medicine Congress, on the 25th & 26th of April 2017 in London. Over two days our event will bring together 300 senior level attendees from academia, research institutes and pharma companies to discuss the current challenges and future perspectives of precision medicine. This event provides an ideal platform to participate in formal 1-1 meetings and informal networking drinks with other key industry figures, as well as providing opportunities to exchange ideas with some of the most influential professionals in the field. The conference programme will consist of 2 interactive streams covering: - Precision Medicine and Diagnostics in Discovery and Clinical Development - Precision Medicine and Genomics Across the two-day event, our expert panel will offer a comprehensive look at critical advances in diagnostic and genomic research. We will also be hosting key biotech solution providers, giving attendees the chance to hear about the very latest state-of-the-art technologies including NGS and rapid Biomarker analysis platforms. The meeting will cover the discovery of diagnostic developments in therapeutic areas. And how to understand the current issues in precision medicine and genomics. The event will be co-located with our Inaugural Advances in Companion Diagnostics Congress. For more information on how to register for the meeting please contact firstname.lastname@example.org.
April 25-26, 2017
TBC, London, Non-U.S., United Kingdom
Oxford Global Conferences are proud to present the Inaugural Advances in Companion Diagnostics Congress, taking place on the 25-26 April 2017 in London. Over two days our event will bring together 300 senior level attendees from academia, research institutes and pharma companies to discuss the current challenges and future perspectives of companion diagnostics. This event provides an ideal platform to participate in formal 1-1 meetings and informal networking drinks with other key industry figures, as well as providing opportunities to exchange ideas with some of the most influential professionals in the field. Companion diagnostics are laboratory tests and test kits used to determine the suitability of patients for tailored or targeted forms of therapy, e.g., therapies that act on unique biochemical pathways or that require specific genotypes or mutations. Diagnostics are used to assist in the identification of genetic mutations with implications regarding health and treatment decisions. Genetic testing has become an important piece of the continuously evolving health-care model. It is now possible to identify diseases before symptoms appear, predict the likelihood of disease development, and implement lifestyle or therapeutic interventions that will reduce or eliminate the effects of disease. Closer investigation into the nature of disease has sometimes revealed a more complex set of interactions than what was previously understood. While human DNA has similarities, there are also many individual differences. On day one our esteemed speakers will discuss the progress of diagnostic development in therapeutic areas. There will be a whole stream dedicated to exploring the opportunities and challenges of diagnostic development, including the regulatory issues surround the tests, and a number of clinical case studies with a focus on biomarkers, exosome markers and glycol-biology. Day one will also focus on the current issues surrounding imaging, with a wide range of talks focussing on different imaging technologies such as digital PCR and personalised molecular imaging. On day two the event will move more toward the advances in molecular diagnostics, with an analysis of how MDx is being applied to key areas such as auto-immune disease and oncology. We will also hear from experts discussing the use the liquid biopsy and the quest to make it more efficient. You will have the opportunity to hear from key figures as to how CDx is being used in new and exciting therapeutic areas such as primary care, rare disease and neuroscience. The conference will also focus on how CDx is being used in collaboration with NGS technologies. For more information please contact Danielle: email@example.com
May 15-16, 2017
Crowne Plaza, Potsdamer, Platz, Berlin, Non-U.S., Germany
SMi is proud to announce the return of their 6th annual Orphan Drugs event to Berlin on the 15th -16th May 2017! The global orphan drug market totaled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019.* With such growth and innovation witnessed in this field now is the best time to discuss and strategize the best route to market. Germany is Europe's largest pharma market but is recognised as having one of the toughest pricing policies in Europe. Smi 6th annual Orphan Drugs conference will discuss the controversial German pricing mechanism as well as bring together leading industry professionals to discuss the latest regulatory developments, explore how to reduce costs and learn from the latest innovations in the orphan drug landscape.
Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation): 2-Day Workshop
May 15-16, 2017
Venue to be announced shortly, Boston, MA, United States
Course Description: The Process Validation Guidelines (January 2011) and the EU Annex 15: Qualification and Validation (October 2015) outline the general principles and approaches the two regulatory bodies consider appropriate elements of process validation for the manufacture of human and animal drugs and biological products, including Active Pharmaceutical Ingredients (APIs).
This two day, interactive Seminar which provides a conduit to enhance your understanding of the Continued Process Verification, will be reviewed in detail: where does it begin; what is included; and, when does it end. Common questions asked by the users of Process Validation include; How does one integrate these two different concepts (Phase 1, 2, and 3 vs. Stages 1, 2, and 3) and where do they merge? Do they exist independently of each other or do they complement each other to enhance, build and provide a product that neither alone could. Questions that may arise include where are cGMPs initiated? To what extent must they be used? Since Stage 3 extends through commercial batch manufacturing, what happens to Phase 3? Does it follow along or with Stage 3? Questions that exist include how one manages special situations to include viral inactivation and removal, impurity clearance, process consistency, process solution stability, endotoxin, bioburden, and other miscellaneous cell culture tests to include DNA and host cell protein. These questions will be addressed within Stage 2 as presented here and include utilization of Process Validation and Phase 1, 2 and 3, where their Guidances blend and where they remain distinct. In particular, Stage 3. Important: Please plan to bring a multidisciplinary group from your Company to gain the most from this very important seminar.
May 15-16, 2017
Copthorne Tara Hotel, London, Non-U.S., United Kingdom
Oxford Global are proud to present the 2nd Annual Advances in Immuno-Oncology Congress, taking place 15-16 May 2017 in London UK. The event features 200 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies. 36 presentations and case studies will focus on the key developments in Immuno-Oncology with specific reference to the discovery of therapeutic areas, pre-clinical and clinical studies, screening, assays and modelling. The congress has 4 interactive streams: • Discovery of Immuno-Oncology Therapies • Pre-clinical Immuno-Oncology • Screening, Assays and Modelling in Immuno-Oncology • Immuno-Oncology: Therapeutic Approaches, Clinical Research and Clinical Trials 14 pre-scheduled one to one meetings, exhibition and informal networking opportunities.
May 15-16, 2017
Berlin, Non-U.S., Germany
SMi is proud to announce the return of their 6th annual Orphan Drugs event to Berlin on the 15th -16th May 2017! The global orphan drug market totaled nearly $123 billion in 2014 and will continue to grow to reach nearly $191 billion by 2019.* With such growth and innovation witnessed in this field now is the best time to discuss and strategize the best route to market.
Manufacturing and Marketing OTC Drugs in Compliance with FDA Regulations (Updated to address recent Homeopathic Drug announcements by FDA & FTC)
May 16-17, 2017
Venue to be announced shortly, Philadelphia, PA, United States
This interactive one-and-a-half-day seminar is intended to educate regulatory and quality professionals regarding the rather complicated regulations that distinguish Non-prescription Drugs from other products such as foods, cosmetics, dietary supplements and prescription drugs that sometimes contain the same ingredients. Recent FDA actions such as the banning of antibacterial soaps and ongoing programs that may impact manufacturers and private label distributors will be discussed. It will explain differences in the way homeopathic and conventional drugs are regulated and update participants on FDA’s application of GMP regulations to manufacturing low risk drugs that could be sold as cosmetics with the same ingredients, but different labeling.
May 16-18, 2017
Pennsylvania Convention Center , Philadelphia, PA, United States
CPhI North America will be the epicenter of pharmaceutical innovation, emerging trends, insights, and community-building connections in North America. It will bring together those seeking powerful partnerships to illuminate the path towards high growth in this ever-evolving industry. The inaugural event will take place on May 16–18, 2017, at the Pennsylvania Convention Center in Philadelphia, PA, adjacent to InformEx, the home of fine and specialty chemicals. Pharmaceutical executives along with R&D, compliance, regulatory, manufacturing, QA/QC, supply chain, packaging, and procurement professionals will gather to build connections to capitalize on emerging trends, further innovation, and tackle industry challenges. The launch of CPhI North America has been strategically timed to take advantage of strong industry growth and innovation while addressing the ever-increasing challenges to the future prosperity of the industry. CPhI North America has been expressly designed to serve the full pharmaceutical value chain. The exhibit floor will be zoned to facilitate a more intimate and efficient experience allowing attendees to customize their experiences. -iCSE: The Drug Development zone will highlight world-class CROs and other organizations serving drug developers. -CPhI North America: The Manufacturing Ingredients zone will consist of active product ingredients (API) and excipient leaders. -FDF: The Finished Drug Products zone will feature leading small and large molecule CDMO/CMOs. -InnoPack: The Packaging zone will showcase packaging innovation. In addition to the zoned exhibit floor populated with leading industry organizations and solutions, CPhI North America will include the following opportunities: -Innovation Zones: These zones will presenting cutting-edge technology, products, and approaches. The zones will allow industry professionals to gather to network and discuss innovations and challenges of common interest and mutual benefit. -Networking Sessions: These events will bring the industry at large together, and smaller targeted events will be held for specific functions or specific areas of interest. -One-on-One Matchmaking: This opportunity will facilitate connections that accomplish individual and organizational objectives. -World-class Educational Programming: CPhI North America has forged strategic partnerships with the American Chemical Society (ACS), the largest scientific association in the world, and CBI, the industry leader in actionable life sciences content and analysis. Through these partnerships, CPhI North America has created rich programming that addresses the full spectrum of the pharmaceutical value chain. The educational programming will include 24 Master Classes covering the most pressing topics within drug development, formulation, manufacturing, and outsourcing. In addition, the programming will include Regulatory Town Hall and keynote sessions with the FDA and leading global regulators.
May 16-18, 2017
Pennsylvania Convention Center, Philadelphia, PA, United States
At InformEx, leading-edge global innovation meets a dynamic community of industry leaders within the evolving fine, specialty, and custom chemicals industry. On May 16–18, 2017, a better-than-ever InformEx will be held at the Philadelphia Convention Center adjacent to CPhI North America’s debut. 340+ InformEx exhibitors and 2,500+ attendees from 30 countries will gather at this hub of fine and specialty chemical innovation. The specialty chemicals industry is changing in very meaningful ways. Chemical product innovation is now often more incremental progress rather than the blockbuster advancements of the 20th century, emerging markets are driving much of the industry’s growth, volatility in numerous end-use markets is difficult to manage, and increasing regulatory demands are creating further complexity. On the other hand, high-performance technologies, value-adding digital technologies and the demand for environmentally friendly products present tremendous opportunities. These industry-driving changes within the fine and specialty chemicals industry created the need to evolve InformEx’s 32-year legacy to meet new market demands. An Evolving Event for a Changing Industry InformEx 2017 has evolved in critical ways while drawing on the decades of experience the organization has serving the fine and specialty chemicals market. This evolution has led to dynamic conference programming, the Innovation Highway, a move to Philadelphia, and adjacency to CPhI North America. The 2017 Conference Program will foster dialogue on innovation and commercialization trends, regulatory challenges, market dynamics, and opportunities for growth within today’s rapidly growing chemical markets, including the broader energy field, personal care, life sciences, and agrochemicals. Educational sessions will highlight opportunities in new innovative sub-segments, such as green chemistry, 3-D printing, and electronic chemicals. The American Chemical Society (ACS), the largest scientific organization in the world, and The Society of Chemical Manufacturers and Affiliates (SOCMA) are serving as strategic partners to help build an outstanding 2017 conference program. InformEx 2017 will feature the Innovation Highway, which will connect InformEx and CPhI. The Innovation Highway will feature opportunities for collaboration and innovation between the specialty chemical and pharmaceutical industries.
May 17-19, 2017
Business Design Centre, London, 52 Upper Street, Islington, London, Non-U.S., United Kingdom
In May 2017 the newly named World Advanced Therapies and Regenerative Medicine Congress, will bring together 800+ attendees and explore the rapidly developing world of ATMPs (Advanced Therapy Medicinal Products). From clinical translation to commercialisation this congress will bring you the most exciting case studies and new data for stem cells, gene therapy, TCRs and gene editing. Experts in every area will help you tackle the process and regulatory hurdles of developing all new therapeutic formats all the way through manufacture and into the clinic. The event will take place alongside the co-located World Precision Medicine Congress and Cord Blood World Europe, hosting 200+ speakers, 7 tracks of content across the 3 days, enabling networking opportunities with 800+ leading industry professionals. Key topics include: . The next generation of ATMPs . Regulation, reimbursement and commercialisation for advanced therapies around the globe . CRISPR and gene editing . Stem cells as a tool for drug discovery . What's next for cell and gene therapy, new era of regenerative medicine? . New paradigms in manufacture: gene therapy and viral vectors . Clinical development of immunotherapy and cell therapy . New frontiers in repair and replacement of diseased tissues and organs . Product, process and manufacturing development of ATMPS
May 22-23, 2017
Copthorne Tara Hotel, Scarsdale Place, Kensington, London, Non-U.S., United Kingdom
The global market for Highly Potent Active Pharmaceutical Ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs. Over a quarter of drugs worldwide now contain HPAPIs, as they have proven to be more effective than other APIs. However, working with APIs high in potency and cytotoxicity comes with many regulations and requirements, and presents pharmaceutical companies with challenges such as handling, containment, cost and security questions. The inaugural Highly Potent Active Pharmaceutical Ingredients conference features key speakers of the industry presenting challenges, issues, innovation and new developments in various areas of HPAPI production, development and manufacturing. Hear about new innovative containment risk assessment tools and containment strategies when handling HPAPI products. Guidance for the evaluation and management of cross-contamination will be addressed, as well as newest control strategies and solutions. This conference will cover many important and in-demand aspects of the HPAPI industry, creating a networking platform for industry professionals and key players to share their knowledge and find innovative new solutions.
May 22-23, 2017
Copthorne Tara Hotel, London, Non-U.S., United Kingdom
In recent years there has been an emerging trend in the global market for Highly Potent Active Pharmaceutical Ingredients, which is largely driven by its major use in oncology for cancer treatment and more often in the form of anti-drug conjugates (ADCs). With this continued development, SMi has been receptive to the steadily increasing market growth and have launched its first Highly Potent Active Pharmaceutical Ingredients conference, set to take place 22nd – 23rd May in London, UK. The conference programme has been produced to enable delegates to gain knowledgeable insight on how to develop highly potent APIs more efficiently, safely and more cost effectively than before. Whether your area of expertise is in process development, scale up, occupational safety or outsourcing, this two day conference is certain to equip you with a wealth of actionable insights. FEATURED SPEAKERS: Alessandro Brigo, Toxicology Project Leader, Pharmaceutical Sciences Andreas Flueckiger, Chief Occupational Health Officer, Roche Gwydion Churchill, Associate Director of Chemistry, Antibiotics Business Unit, AstraZeneca Ildiko Ziegler, Distinguished Validation Expert, Gedeon Richter Hungary Jack Brown, Senior Principal Scientist, Boehringer Ingelheim James Evans, Vice President CMC, NuCana BioMed Jason Hamm, Director of Chemical Development Operations, Bristol-Myers Squibb Richard Denk, Head Sales Containment, SKAN AG CONFERENCE HIGHLIGHTS Address the challenges of working with HPAPIs and approaches to scale-up Discuss strategies for CMO selection and solutions to better communication and transfer Hear about Teva API’s Operational Excellence and QC Lab Transformation Gain insight into the ISPE contamination Manual covering containment issues from the PDE/ OEL to life cycle Learn about Health Hazard Assessment Classifications and the toxicological criteria of potent compounds
May 22-23, 2017
Copthorne Tara Hotel, Kensington, London, Non-U.S., United Kingdom
Created with an expert scientific advisory board, Pain Therapeutics 2017 will hone in on the latest innovations and novel approaches to pain therapy and analgesic drugs as well as look at the practicalities of using animal models and translational biomarkers in pain research. Aimed at an audience of scientific leaders and senior specialists in neuroscience, CNS, clinical operations and pharmacology, presentations from a selection of hand-picked pharmaceutical companies currently developing novel treatments in pain, will keep attendees at the forefront of medical breakthroughs to adapt to the growing need towards minimising opioid dependency and new drug discovery. Exclusive new findings from phase II clinical trials will be just some of the highlights at the 17th annual show when it returns to London this spring.
May 22-23, 2017
Capthone Tara Hotel , London , Non-U.S., United Kingdom
The global market for Highly Potent Active Pharmaceutical Ingredients is currently on a growth fast track, largely driven by its major use in oncology for cancer treatment and more often in the form of ADCs. Over a quarter of drugs worldwide now contain HPAPIs, as they have proven to be more effective than other APIs. However, working with APIs high in potency and cytotoxicity comes with many regulations and requirements, and presents pharmaceutical companies with challenges such as handling, containment, cost and security questions. This conference will cover many important and in-demand aspects of the HPAPI industry, creating a networking platform for industry professionals and key players to share their knowledge and find innovative new solutions
May 29-30, 2017
Austria Trend Hotel Savoyen, Vienna, Non-U.S., Austria
Vienna calling! Pharma Business Development Insiders choose Vienna as one of the best summer venues for the 64th euroPLX Partnering Conference. Seeking and offering business opportunities is what the 64th euroPLX international pharma partnering conference is all about. Once again it will be attended by pharma business development key players. It is the preferred business platform for business development decision makers of more than 1,500 pharma and biotech companies from 81 countries worldwide since more than 21 years: CEOs, owners, vice presidents, directors, and BDandL managers of drug developing, producing, or marketing and distribution companies. For sponsorship opportunities please download the Sponsorship Opportunites Flyer (PDF) from the euroPLX 64 Vienna page or contact us.
June 8-9, 2017
HYATT REGENCY MISSION BAY, San Diego, CA, United States
Drawing on from the huge success of SMi’s Pharmaceutical Microbiology UK events, SMi is delighted to announce the launch of Pharmaceutical Microbiology USA. The seventh in its series, this event will take place in San Diego, on the 8th and 9th June 2017. Aimed at Microbiologists, Quality Control and Quality Assurance Managers, Pharmaceutical Microbiology USA 2017 will address the current challenges and developing trends of the pharmaceutical microbiology field. Through a series of presentations from handpicked industry experts, two pre-conference workshops and an additional interactive training session, the agenda will discuss hot topics such as rapid microbiology methods (RMM), risk assessment, challenges in endotoxin recovery, environmental monitoring, sterility assurance, data integrity and much more… Speaker Line-Up Includes: Janssen, Amgen, Takeda, Merck, Bimeda, Excellent Pharma Consulting, Roche Molecular Systems, Microrite and many more…
June 12-13, 2017
Hotel Palace Berlin, Berlin, Non-U.S., Germany
This summit brings together over 250 key opinion leaders and senior industry experts in drug discovery, to discuss the latest innovative discovery strategies in different therapeutic areas as well as the most effective enabling technologies and solutions. Our co-located 5th Discovery Chemistry & Drug Design Congress provides an unprecedented opportunity to gain insights from key presenters of the computational chemistry, discovery chemistry and medicinal field.
June 12-13, 2017
Taipei, Taiwan, Taipei, Non-U.S., Taiwan
Conference Series LLC is a renowned organization that organizes highly notable conferences throughout the globe. Currently we are bringing forth “International Conference on Pharmaceutical and Biomedical Engineering” (Pharma Engineering 2017) scheduled to be held during June 12-13, 2017 at Taipei, Taiwan. The conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmaceutical and Biomedical Engineering. Conference Theme: “Recent Innovations in Pharmaceutical and Biomedical Engineering”. Scientific Sessions: • Pharmaceutical Engineering • Drug Engineering • Pharmaceutical Technology • Pharmaceutical Analysis • Process Engineering • Medical Devices and Imaging • Biomedical Engineering • Biomechanics • Cell & Tissue Engineering • Bioinstrumentation and Bio imaging • Biomaterials • Genetic Engineering • Regulatory Compliance Who should attend??? With members from around the world focused on learning about Pharmaceutical and Biomedical Engineering and the most recent techniques, developments, and the newest updates in this field; Target audience expected for this conference include Pharmaceutical Industries, Biomedical Engineering research institutes, Pharmaceutical Manufacturing Companies, Pharmaceutical Faculty, Biomedical Engineering Faculty, Pharmaceutical and Biomedical Engineering Associations and Societies, Pharmaceutical Researchers, Pharmaceutical & Biomedical students, scientists, Business Entrepreneurs, Consultancies offering Pharmaceutical & Biomedical courses and many more.
June 19-21, 2017
Hilton London Docklands Riverside 265 Rotherhithe St, London SE16 5HW, United Kingdom, London, Non-U.S., United Kingdom
Euro Mass Spectrometry 2017 covers a wide range of critically important sessions from basic research to recent innovations. It is an especially based to learn and share knowledge on current research and applications of Mass Spectrometry. The main theme of the conference is “Recent advancements, novel applications and future approaches of Mass Spectrometry”. The conference also provides delegate’s opportunity to the researchers and analytical scientists. Euro Mass Spectrometry 2017 Renowned Speakers Athula Attygalle, Center for Mass Spectrometry, Stevens Institute of Technology, USA Hermann Wollnik, New Mexico State University, USA Eduard Rogatsky, Wadsworth Center, USA K. W. Michael Siu, University of Windsor, Canada Marek M Kowalczuk, University of Wolverhampton, UK Achille Cappiello, LC-MS Laboratory, University of Urbino, Italy Elliot R. Bernstein, Colorado State University, USA CHEN Jianmin, Fudan University, China Miho TANAKA, University of Marine Science and Technology, Japan Chi-Kit Andy Siu, City University of Hong Kong, China Giovanni Meloni, University of San Francisco, USA Alexander A. Sysoev, National Research Nuclear University MEPhI, Russia Zhang Qi, Tulane University, USA Sermin Tetik, University of Marmara, Turkey Magnus S. Magnusson, University of Iceland, Iceland Dong An, Fudan University, China Katarzyna Pawlak, Warsaw University of Technology, Poland David J. Merkler, University of South Florida, USA Sofia Nikolaou, University of São Paulo, Brazil Lingzhi Gong, Queen Mary University of London, UK Wanghsien Ding, National Central University, Taiwan Vasile I. Furdui ,Ministry of the Environment and Climate Change, Canada J. Fernando Huertas-Pérez, Nestlé Research Center, Switzerland Purushottam Chakraborty, Saha Institute of Nuclear Physics, India Vladimir Zaichick, Medical Radiological Research Centre, Russia and Many More Speakers For more details of the conference, please visit: http://www.massspectra.com/europe/ Please book your speaker slot by submitting your abstract online at: http://www.massspectra.com/europe/abstract-submission.php Your valued presence will enhance the scientific essence of the conference and help to make it a grand success, and hope that your stay will be enjoyable and memorable. Thanks & Regards , Adam Smith Program Director Conference Series LLC 5716 Corsa Ave., Suite 110, Westlake Los Angeles, CA 91362-7354, USA Office P: +1-702-508-5200 Ext: 8047
June 22-23, 2017
Sao Paulo, Brazil, Sao Paulo, Non-U.S., Brazil
Overview: • This interactive two-day course explores proven techniques for reducing costs associated with implementing, using, and maintaining computer systems in regulated environments. • Many companies are outsourcing IT resources and getting involved with Software as a Service (SaaS) and cloud computing. These vendors are not regulated and therefore regulated companies must ensure compliance for both infrastructure qualification and computer system validation. It is the regulated company that wants to avoid FDA form 483s and warning letters. The seminar is intended for regulated companies, software vendors, and SaaS/Cloud providers. • The instructor addresses the latest computer system industry standards for data security, data transfer, audit trails, electronic records and signatures, software validation, and computer system validation. • Today the FDA performs both GxP and Part 11 inspections, the Europeans have released an updated Annex 11 regulation that expands Part 11 requirements and companies must update their systems and processes to maintain compliance. • This seminar will help you understand the specific requirements associated with local and SaaS/cloud hosting solutions. • Nearly every computerized system used in laboratory, clinical, manufacturing settings and in the quality process has to be validated. • Participants learn how to decrease software implementation times and lower costs using a 10-step risk-based approach to computer system validation. • Finally, the instructor reviews recent FDA inspection trends and discusses how to streamline document authoring, revision, review, and approval. • This course benefits anyone that uses computer systems to perform their job functions and is ideal for regulatory, clinical, and IT professionals working in the health care, clinical trial, biopharmaceutical, and medical device sectors. It is essential for software vendors, auditors, and quality staff involved in GxP applications. Course Objectives: • Understand what is expected in Part 11 and Annex 11 inspections • Avoid 483 and Warning Letters • Learn how to buy COTS software and qualify vendors. • Implement a computer system using risk-based validation to gain maximum productivity and reduce cost by as much as two thirds • Requirements for local, SaaS, and cloud hosting • How to select resources and manage validation projects • "Right size" change control methods that allows quick and safe system evolution • Minimize the validation documentation to reduce costs without increasing regulatory or business risk • Write test cases that trace to elements of risk management • Protect intellectual property and keep electronic records safe Who will benefit: • QA, IT, management • all GxP system users Agenda: Day 1 Schedule Lecture 1: Introduction to the FDA • How the regulations help your company to be successful • Which data and systems are subject to Part 11 Lecture 2: 21 CFR Part 11/Annex 11 - Compliance for Electronic Records and Signatures • What Part 11 means to you, not just what it says in the regulations • Avoid 483 and Warning Letters • Explore the three primary areas of Part 11 compliance: SOPs, software product features, and validation documentation • How SaaS/cloud computing changes qualification and validation • Ensure data integrity, security, and protect intellectual property • Understand the current computer system industry standards for security, data transfer, and audit trails • Electronic signatures, digital pens, and biometric signatures • SOPs required for the IT infrastructure • Product features to look for when purchasing COTS software • Reduce validation resources by using easy to understand fill-in-the-blank validation documents Lecture 3: The Five Keys to COTS Computer System Validation • The Who, What, Where, When, and Why of CSV Day 2 Schedule Lecture 1: Ten-Step Process for COTS Risk-Based Computer System Validation • Learn which documents the FDA expects to audit. • How to use the risk-based validation approach to lower costs. • How to link requirements, specifications, risk management, and testing. • Document a computer system validation project using easy to understand fill-in-the-blank templates. • Based on: "Risk-Based Software Validation - Ten Easy Steps" (Davis Horwood International and PDA - www.pda.org, 2006). Lecture 2: How to Write Requirements and Specifications • Workshop for writing requirements and then expanding them for specifications Lecture 3: How to Conduct a Hazard Analysis/Risk Assessment-Exercise • Step-by-step instructions for performing and documenting a risk assessment, and how to use the results to reduce validation documentation. Lecture 4: Software Testing • Reduce testing by writing test cases that trace to elements of risk management. • How to write efficient test cases Lecture 5: System Change Control • How to manage a validated system with minimal documentation Lecture 6: Purchasing COTS Software • How to purchase COTS software and evaluate software vendors. Lecture 7: Cost Reduction Without Increasing Regulatory or Business Risk • How to save money • How to increase quality • How to increase compliance with less documentation Speaker: David Nettleton FDA Compliance Specialist Computer System Validation's principal, David Nettleton is an industry leader, author, and teacher for 21 CFR Part 11, Annex 11, HIPAA, software validation, and computer system validation. He is involved with the development, purchase, installation, operation and maintenance of computerized systems used in FDA compliant applications. He has completed more than 260 mission critical laboratory, clinical, and manufacturing software implementation projects. His most popular book is Risk Based Software Validation - Ten easy Steps, which provides fill-in-the-blank templates for completing a COTS software validation project. Services are available to guide companies to create and maintain the systems and procedures required to pass regulatory inspections: product features, vendor audits, software validation, SOPs, training, gap analysis, remediation plans, and project management. Projects involve: medical devices, blood bank, clinical trial, corrective action, document control, electronic data capture, Excel spreadsheets, laboratory instruments, laboratory information management (LIMS), manufacturing, enterprise resource planning, toxicology systems, and VMWare. David Nettleton is also the co-author of: • Managing the Documentation Maze - Answers to Questions You Didn't Even Know to Ask (Wiley - www.wiley.com) 2010 • Electronic Record Keeping; Achieving and Maintaining Compliance with 21 CFR Part 11 and 45 CFR Parts 160, 162, and 164 (Interpharm/CRC - www.crcpress.com, 2004) • Commercial Off-the-Shelf (COTS) Software Validation for 21 CFR Part 11 Compliance (Davis Horwood International and PDA - www.pda.org, 2003). Location: Sao Paulo, Brazil Date: June 22nd, 23rd, 2017 and Time: 8:30 AM to 5:00 PM Venue: WILL BE ANNOUNCED SOON Price: Price: $1,095.00 (Seminar Fee for One Delegate) Register for 5 attendees Price: $3,285.00 $5,475.00 You Save: $2,190.00 (40%)* Until May 10, Early Bird Price: $1,095.00 From May 11 to June 20, Regular Price: $1,295.00 Quick Contact: NetZealous DBA as GlobalCompliancePanel Phone: 1-800-447-9407 Fax: 302-288-6884 Email: firstname.lastname@example.org Website: http://www.globalcompliancepanel.com Registration Link -http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900948SEMINAR?channel=mailer&camp=seminar&AdGroup=pharmamanufacturing_June_2017_SEO Follow on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel
June 24-27, 2017
CLARION CONGRESS HOTEL PRAGUE, Freyova 33 - 190 00, Prague, Non-U.S., Czech Republic
The main focus of EACPT 2017 is the role of clinical pharmacology in personalized pharmacotherapy, both a priori – pharmacogenetics – and a posteriori (therapeutic drug monitoring). The topic list includes a broad spectrum of topics that relate to Clinical Pharmacology: - Access to medicines. Innovation and sustainability of National Health Systems - Cardiovascular pharmacology and diabetes - Clinical toxicology - Clinical trials methodology - Drug development and regulatory sciences - Drug Safety and pharmacovigilance - Education - Global Health - Research Ethics - Pharmacoeconomics and health technology assessments - Inflammatory and immune based diseases and treatments - Infectious diseases. Antibiotics, antivirals, antifungals. - Neuro-psychopharmacology - Oncology - Orphan medicines - Research using Electronic Health Records. - Pharmacology of pain - Pharmacogenetics and pharmacogenomics - Pharmacokinetics, TDM, PK-PD modelling and drug interactions - Special populations
June 27-27, 2017
Hyatt Regency Hotel, New Brunswick, NJ, United States
DCAT Sharp Sourcing 2017 is a conference and networking event that provides peer and customer insight on the best practices and practical ways for optimizing pharmaceutical manufacturing and supply networks. The event is designed for senior to mid-level executives engaged in sourcing, procurement, supply management, and external manufacturing and their business counterparts on the supply side. It is organized by the Drug, Chemical & Associated Technologies Association (DCAT).
June 28-29, 2017
McEnery Convention Center, San Jose, CA, United States
Sensors Expo & Conference is the only industry event in North America exclusively focused on sensors and sensor-integrated systems. For over 30 years, Sensors has brought technical innovation and thought leadership to engineers involved in the development and deployment of sensors and sensing systems. The 3-day program explores cutting-edge trends and applications including Energy Harvesting & Power, Emerging Technologies, Flexible & Wearable Tech, IoT & Wireless, Measurement & Detection, MEMS & Sensors, Novel Sensor Applications, Optical Sensing & Detection, Sensors & Embedded Systems, and Sensor Data in an information-packed Conference Program and reflects those trends throughout the Exhibit Floor with new products, technology pavilions, demos, and a showcase of 300+ of the latest sensors on display.
Join us at the industry’s premier gathering of engineers to find the solutions for your present challenges while exploring sensing technologies that are driving tomorrow’s solutions.
Special offer for subscribers/members to attend Sensors 2017: Use code PM100 for $100 off Gold & Main Conference Passes or a FREE Expo Hall Pass in advance. Visit www.sensorsexpo.com to register today and for the latest information on the 2017 event.
June 29 - July 1, 2017
Melia Valencia , Valencia , Non-U.S., Spain
Recommended: Pharma Conferences |Pharmaceutical Conferences | Pharmacy Conferences Magnus Group invites all the participants to World Conference on Pharmaceutics and Drug Delivery Systems (PDDS 2017) which is going to be held during June 29- July 01, 2017 at Valencia, Spain. The (PDDS 2017) World Conference on Pharmaceutics and Drug Delivery Systems will bring together a collection of investigators who are at the forefront of their field, and will provide opportunities for junior scientists and graduate students to interactively present their work and exchange ideas with established senior scientists. At Congress, you’ll learn the latest developments in Drug Delivery Systems in sessions led by renowned scientists across the globe. Plus, you’ll have the opportunity to connect with more than 500 of your peers and celebrate your profession. You’ll leave better educated and more invigorated than you thought possible. We wish to see you in Valencia, Spain. Recommended: Pharma Conferences |Pharmaceutical Conferences | Pharmacy Conferences
July 6-7, 2017
Hilton Zurich Airport, Opfikon, CA, Switzerland
Overview: • This interactive two-day course explores proven techniques for reducing costs associated with implementing, using, and maintaining computer systems in regulated environments. • Many companies are outsourcing IT resources and getting involved with Software as a Service (SaaS) and cloud computing. These vendors are not regulated and therefore regulated companies must ensure compliance for both infrastructure qualification and computer system validation. It is the regulated company that wants to avoid FDA form 483s and warning letters. The seminar is intended for regulated companies, software vendors, and SaaS/Cloud providers. • The instructor addresses the latest computer system industry standards for data security, data transfer, audit trails, electronic records and signatures, software validation, and computer system validation. Who will benefit: • QA, IT, management • all GxP system users Speaker: David Nettleton FDA Compliance Specialist Computer System Validation's principal, David Nettleton is an industry leader, author, and teacher for 21 CFR Part 11, Annex 11, HIPAA, software validation, and computer system validation. He is involved with the development, purchase, installation, operation and maintenance of computerized systems used in FDA compliant applications. He has completed more than 260 mission critical laboratory, clinical, and manufacturing software implementation projects. His most popular book is Risk Based Software Validation - Ten easy Steps, which provides fill-in-the-blank templates for completing a COTS software validation project. Location: Zurich, Switzerland Date: July 6th and 7th, 2017and Time: 9:00 AM to 6:00 PM Venue: Hilton Zurich Airport Address: Hohenbuhlstrasse 10, 8152 Opfikon-Glattbrugg, Switzerland. +41 44 828 50 50 Price: Price: $1,695.00 (Seminar Fee for One Delegate) Register for 5 attendees Price: $5,085.00 $8,475.00 You Save: $3,390.00 (40%)* Until May 25, Early Bird Price: $1,695.00 from May 26 to July 04, Regular Price: $1,895.00 Quick Contact: NetZealous DBA as GlobalCompliancePanel Phone: 1-800-447-9407 Fax: 302-288-6884 Email: email@example.com Website: http://www.globalcompliancepanel.com Registration Link - http://www.globalcompliancepanel.com/control/globalseminars/~product_id=900924SEMINAR?channel=mailer&camp=Seminar&AdGroup=pharmamanufacturing_Jul_2017_SEO Follow on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel
July 12-13, 2017
Venue to be announced shortly, San Francisco, CA, United States
This course is designed to help scientists and engineers understand the statistical methods used in process and product development. Variability is part of every process, design of experiments helps to separate systematic variability from special cause variability. You will get a chance to examine the different sources of variability how it relates to analytical method development, process improvement and sample size selection. The concept of experimental budget will be introduced to help you plan the total number of experiments needed. You will also learn to improve process output characteristics including quality, cost, and robustness through generating empirical models of your processes in the fewest experiments possible. Note: Use coupon code NB5SQH8N and get 10% off on registration.
July 13-14, 2017
Golden Tulip Berlin - Hotel Hamburg, Berlin, Non-U.S., Germany
Emerging Global Market of HPLC & Chromatography Global HPLC Congress Conference Series has been instrumental in conducting international HPLC Conference for past three years, and is very excited to expand its reach in Europe, America and Asia Pacific continents. Previous meetings were held in major cities like London, New Orleans, and Kuala Lumpur, with success in the previous meetings we have scheduled our future meetings and conferences in three continents. 3rd HPLC congress is to be held during July 10-11, 2017 Berlin, Germany. 6th Mass Spectrometry Meeting scheduled in Osaka, Japan. 4th Conference and Exhibition on HPLC is planned to be conducted at Boston, USA during August 2018. The global chromatography instruments market is segmented on the basis of systems, consumables, applications, and regions. The report studies the global chromatography instruments market for the forecast period of 2015 to 2020. The market is expected to reach USD 9.223 Billion by 2020 from USD 7.062 Billion in 2015, at a CAGR of 5.5%. It is anticipated that North America and Europe will continue to lead the market over the next five years; the chromatography market in Asia will expand and increase its market share. The drivers behind the expansion are two-fold: first the expansion of local companies in Asia and secondly, Western pharma outsourcing its research and manufacturing operations to Asia, particularly China and India. “The global chromatography systems market is driven by the rising awareness of consumers due to the growing number of conferences and exhibitions. Furthermore, the technological innovation in chromatography instruments will also propel the global chromatography market.” says Katarzyna Pawlak, Warsaw University of Technology, Poland. Everyone interested in the future of emerging - omics Analytical and Industrial techniques majorly in HPLC are encouraged to attend the future conferences. Connect with our social network pages to get regular industry updates. About us: ConferenceSeries.com hosts 3000+ Global Events that includes over 1000+ International Conferences, 1000+ Symposiums and 1000+Workshops and preconference workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management fields. Over 25 Million visitors flock to our websites to observe the attest developments in these fields. Program Coordinator HPLC Congress 2017 conferenceseries.com Website: www.hplc.conference.com E-mail: firstname.lastname@example.org
July 31 - August 1, 2017
Milan, Italy, Milan, Non-U.S., Italy
The Future of Antibiotics: Key Opportunities & Emerging Therapies Antibiotics Conference Series Conference Series has been instrumental in conducting international Antibiotics meetings for seven years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like Las Vegas, Manchester, Australia, with success the meetings again scheduled in three continents. 3rd Antibiotics Meeting to be held during July31- Aug 02, 2017 at Milan, Italy. 4th Antimicrobials Meeting is scheduled during August 24-25, 2017in Toronto, Canada and 5th Antibiotics meeting will be scheduled at Japan. The global Antibiotics market was valued at $39.6 billion in 2013 and is expect to reach $41.2 billion by 2018, at a CAGR of 0.8%. The rising demand for animal protein products in the emerging countries and the increasing trend for companion animal ownership are some of the factors driving the growth of antibiotics market. Major companies are establishing their subsidiaries in these regions and are investing in building stronger footholds in these countries. The Asian and Latin American region form the most promising markets in the world. However, the Asia-Pacific region represents a significant growth opportunity for the Antibiotics market during the forecast period of 2014 to 2019. “If we fail to act, we are looking at an almost unthinkable scenario where antibiotics no longer work and we are cast back into the dark ages of medicine where treatable infections and injuries will kill once again.” says David Cameron UK Former Prime Minister. Everyone interested in the future of emerging -an omics healthcare technique majorly in Antibiotics is encouraged to attend. Connect with our social network pages to get regular industry updates. About us: ConferenceSeries.com hosts 3000+ Global Events that includes over 1000+ International Conferences, 1000+ Symposiums and 1000+Workshops and preconference workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management fields. Over 25 Million visitors flock to our websites to observe the attest developments in these fields. Isaac Bruce Program Manager Antibiotics 2017 Conference Series Direct: (702) 508-5200 Customer Service: +1 (800) 216 6499 Email: email@example.com conferenceseries.com www.conferenceseries.com
July 31 - August 2, 2017
Milan, Non-U.S., Italy
Neuropharmacology: Major Challenges and Breakthroughs Global Neuropharmacology Conference Series Conference Series has been instrumental in conducting International Neuropharmacology meetings for five years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like San Antonio, Tokyo, Madrid, with success the meetings again scheduled in three continents. 7th Neuropharmacology Meeting to be held during July 31-Aug 02, 2017 at Milan, Italy. 8th Neuropharmacology Meeting is scheduled in USA. 10th International Conference on Neuropharmacology and Neuropharmaceuticals planned to be conducted at Dubai, UAE during Oct 23-24, 2017. The neuropharmacology market is segmented on the basis of technology, application, and region. The global neurovascular devices/interventional neurology market is poised to reach $2,370.4 Million by 2020 growing at a CAGR of 8.4% from 2015 to 2020. The global neuromodulation market is expected to grow at a CAGR of 11.2% from 2015 to 2020, to reach $6.20 Billion by 2020 from $3.65 Billion in 2015. North America dominated the neuroscience market in 2013, with revenue valued at over USD 9,500 million. Asia-Pacific is expected to witness the fastest growth from 2015 to 2020 due to the presence of high unmet medical needs, rising patient awareness regarding nervous system disorders, and rising healthcare expenditures in emerging economies of India and China. "Conference was great and I am confident that future will be going to be successful! Diversity and qualities of the work presented in this conference excellent especially clinical implications of the neuropharmacological drugs! "says Dr Gjumrakch Aliev, President of GALLY International Biomedical Research Consulting LLC. USA . Everyone interested in learning of how drugs influence cellular function in the nervous system is encouraged to attend. Connect with our social network pages to get regular industry updates. About us: ConferenceSeries.com hosts 3000+ Global Events that includes over 1000+ International Conferences, 1000+ Symposiums and 1000+Workshops and preconference workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management fields. Over 25 Million visitors flock to our websites to observe the attest developments in these fields. Program Coordinator Neuropharmacology 2017 conferenceseries.com www.neuro.pharmaceuticalconferences.com E-mail: firstname.lastname@example.org, +1-702-508-5200
August 28-29, 2017
The Westin Copley Place Boston Hotel, Boston, MA, United States
The growth of biopharma and patient compliance issues have encouraged us to adopt a drug delivery mind set from discovery through to production. Every year we see innovation and breakthroughs at every level of drug development. The DDF Summit brings the most innovative and exciting studies to you.
September 25-27, 2017
Hilton Atlanta Airport, 1031 Virginia Ave, Atlanta, GA, United States
Mass Spectrometry 2017 is a unique opportunity to discuss best practices within the laboratory research and those in other industries if the people are doing related things getting a variety of viewpoints can help us see where we can change or improve our own ideas and processes. Mass Spectrometry 2017 conference designed in all aspects of application including electrospray ionization and mass spectrometry imaging. There will be many seminars, workshops and technical sessions take place which will catch the attention of the professionals to attend Mass Spectrometry conference and it would enormously enrich our knowledge in understanding the current requirements of the global pharmaceutical industry and LCMS/GCMS.
September 28-29, 2017
Hilton Atlanta Airport 103, Virginia Ave Atlanta, Georgia 30354, USA, Atlanta, GA, Australia
Global Analytical chemistry Conference Series Conference Series has been instrumental in conducting international meetings on analytical chemistry and related fields for seven years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like Spain, Orlando, Las Vegas, china, with success the meetings again scheduled in three continents. 9th International Conference and Exhibition on Analytical & Bioanalytical Techniques, to be held during September 27-29, 2017 at Atlanta, USA; 4th World Congress on Chromatography during August 07-09, 2017 at Rome, Italy; 6th Global Congress on Mass Spectrometry during October 19-20, 2017 at Osaka, Japan. The global analytical chemistry market was valued at $40,308.8 million in 2011 and is predicted to achieve $59,319.2 million by 2016; growing at a CAGR of 8 May 1945 from 2011 to 2016. Analytical chemistry market and the life sciences, by technology studied during this report area unit metameric as natural science reagents and analytical reagents; of that natural science phase accounted for the biggest share of 59.37% of the full market in 2011.North America dominated the analytical reagent market with 46.28% share in 2011. Thriving completion of the primary section of the Human ordination Project, prior schedule, has given rise within the U.S. chemical agent market. The Asian market, however, shows bigger opportunities, in comparison to different regions, with the best CAGR of 11.8% from 2011 to 2016; because of inflated analysis outsourcing activities within the life technology field. According to IMS (Intercontinental Marketing Services) Health study report, in 2011 Spain became the fourth largest pharmaceutical market in Europe with a market size of $22.7 billion. The market is dominated by branded medicines with a share of about 88% value wise. Presently few Pharm companies in Spain have received approvals from US Food and Drug Administration (US FDA), European Medicines Agency (EMA), Pharmaceuticals and Medical Devices Agency, Japan (PMDA). Spectrometry segment has the largest share (33.8%) followed by chromatography (22%) in the year 2011. The spectrometry market is driven by the coupling of mass spectrometry with chromatography techniques, growing 9.4% from 2011 to 2016. “I’m driven by how we can use new materials to improve analytical systems and ultimately enable more portable separation science applications.” Says Emily Hilder, Director of ARC Training Centre for Portable Analytical Technologies. Everyone interested in the future of emerging analytical techniques and in related field’s ofChemistry is majorly encouraged to attend. Connect with our social network pages to get regular industry updates. About us: ConferenceSeries.com hosts 3000+ Global Events that includes over 1000+ International Conferences, 1000+ Symposiums and 1000+Workshops and preconference workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management fields. Over 25 Million visitors flock to our websites to observe the attest developments in these fields. Program Coordinator Analytica 2017 conferenceseries.com http://chemistry.conferenceseries.com/ Email: email@example.com
October 16-18, 2017
Hilton New York JFK Airport Hotel, NEW YORK, NY, United States
Frontiers Innovations in Drug Delivery Technology Global Drug Delivery Conference Series Conference Series has been involved in conducting international drug delivery meetings for ten years, and very enlivened to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like Madrid, New Orleans and Dubai, with success the meetings were again scheduled in three continents. International Conference and Exhibition on Nanomedicine and Drug Delivery to be held during May 29-31, 2017 Osaka, Japan. 10th International Conference and Exhibition on Pharmaceutics & Novel Drug Delivery Systems to be held during March 13-15, 2017 London, UK. 11th World Drug Delivery Summit to be held during October 16-18, 2017 New York, USA. In 2012 GlaxoSmithKline generated 8.1 billion U.S. dollars of prescription drug revenue in Europe. Global prescription drug sales are expected to reach about one trillion U.S. dollars by 2020. There is an increasing growth in sales of biological products in Europe. The global advanced drug delivery market should grow from roughly $178.8 billion in 2015 to nearly $227.3 billion by 2020, with a compound annual growth rate (CAGR) of 4.9%. Analyses of global market trends, with data from 2013, estimates for 2015, and projections of compound annual growth rates (CAGRs) to 2020 in America. Asia-Pacific region is expected to grow at a faster CAGR owing to presence of high unmet healthcare needs, research collaborations and increase in drug delivery research funding in emerging economies such as China, India and other economies in the region. "Examples of the diverse dug delivery topics that will be covered in this comprehensive conference include “Next generation advancements in Drug Delivery Systems.” The meeting will focus on recent advances in drug delivery research in vitro, in vivo and clinical research area all of diseases especially neurodegeneration, cancer, cardio- and cerebrovascular disorders" says Dr. Gjumrakch Aliev, President and CEO of GALLY International Biomedical Research Consulting LLC. Everyone interested in the future of emerging pharmaceutical techniques majorly in Drug Delivery is encouraged to attend. Connect with our social network pages to get regular industry updates. About us: ConferenceSeries.com hosts 3000+ Global Events that includes over 1000+ International Conferences, 1000+ Symposiums and 1000+Workshops and preconference workshops on diverse Medical, Pharmaceutical, Clinical, Engineering, Science, Technology, Business and Management fields. Over 25 Million visitors flock to our websites to observe the attest developments in these fields. Program Coordinator Drug Delivery 2017 conferenceseries.com http://drugdelivery.pharmaceuticalconferences.com/2016 E-mail: firstname.lastname@example.org, +1- 1-702-508-5200 EXT: 8046
November 1-3, 2017
Wellcome Genome Campus, Wellcome Genome Campus Hinxton, CB10 1RQ, Cambridge, Non-U.S., United Kingdom
Held with the support of the Sanger Institute, the EBI the Global Alliance for Genomics and Health and The Pistoia Alliance, BioData World Congress aims to showcase innovation, demonstrate success and break through the obstacles and barriers to ensure that the innovations in genomics get to the patient with speed and efficiency. With a mixture of keynote sessions, roundtables, focused work tracks, site visits, product demonstrations and networking parties, this event will push the boundaries in order to realise the power of big data in precision medicine.
November 28-29, 2017
Sandton Convention Centre, 161 Maude Street, Sandton, Non-U.S., South Africa
Saphex is rapidly establishing itself as the most strategic industry event in the South African region that brings together all major stakeholders – industry leaders, policy-makers, regulators, academics, investors, scientists and patient representatives, to tackle the most pressing issues the industry is facing. With over 2000 visitors expected at Saphex 2017, there will be ample opportunity for you to connect and establish relationships with fellow professionals from the pharmaceutical industry. We are also anticipating over 130 exhibitors and over 100 countries represented at the event. The event will incorporate an exhibition and a conference, delivering business contacts and forging strategic alliances in combination with the knowledge and information that you will need to win in the South African pharmaceutical sector. Saphex will be held under the theme, 'Continuing development of the South African Pharmaceutical Industry: Forging ideas for the future composition of the sector'. Aiming to explore the current composition of the industry in South Africa, and inviting several experts in their respective fields to give their opinion on where the future of the market may lead. The approach that companies pursue will hinge upon their individual goals. Inevitably companies will need to decide how to satisfy contending stakeholder demands while pursuing sustainable growth in a competitive market.